What are Collegium Pharmaceutical, Inc.'s profit margins?

Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.

Where do Collegium Pharmaceutical, Inc.'s ratios come from?

Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Collegium Pharmaceutical, Inc. COLL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	60.7%+3.0pp	59.3%-0.4pp	57.2%-5.1pp	56.7%-5.3pp	57.7%-2.3pp
Operating margin	23.7%+2.3pp	23%-3.9pp	20.7%-11.5pp	18.4%-17.0pp	21.4%-12.4pp
Net margin	9.4%+2.8pp	8.1%-2.9pp	7.7%-7.1pp	5.1%-12.2pp	6.6%-9.8pp
EBITDA margin	31.1%-18.9pp	30.7%-23.0pp	36%-21.0pp	40.4%-19.8pp	50%-9.6pp
Free cash flow margin	41.4%+10.4pp	42%+8.3pp	38.2%+4.6pp	29.9%-17.9pp	31%-23.4pp
Returns
Return on equity	27.4%+8.2pp	23.7%-8.9pp	23%-19.9pp	16.2%-31.7pp	19.2%-27.2pp
Return on assets	4.6%+1.4pp	3.8%-1.1pp	3.6%-2.7pp	2.7%-6.1pp	3.2%-4.8pp
Return on invested capital	172.1%+17.8pp	125.6%—	68.1%—	103.6%—	154.3%—
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Inventory turnover	13.3×+5.1×	12.8×+5.3×	8.5×+2.3×	9.3×+1.1×	8.2×+1.1×
Liquidity
Current ratio	1.7×+0.6×	1.6×+0.6×	1.4×+0.4×	1.2×+0.1×	1.1×-0.1×
Quick ratio	1.7×+0.7×	1.5×+0.7×	1.3×+0.4×	1.1×+0.1×	1×-0.1×
Cash ratio	0.7×+0.4×	0.6×+0.4×	0.3×+0.2×	0.3×-0.1×	0.2×-0.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-1.1×-0.8×	-1×-0.8×	-0.5×-0.4×	-0.4×+0.1×	-0.3×+0.3×
Interest coverage	2.4×+0.6×	2.2×-0.1×	1.8×-0.9×	1.6×-1.2×	1.8×-0.6×
Per Share
Book value per share	$7.80+9.2%	$7.53+31.9%	$6.97+19.5%	$5.94+10.8%	$7.14+33.1%
Valuation
Market capitalization	$1.15B+20.4%	$1.46B+58.4%	$1.1B-11.4%	$967.8M-8.1%	$959.13M-22.7%
Enterprise value	$869.67M+2.5%	$1.22B+45.9%	$958.04M-21.0%	$856.64M-3.4%	$848.54M-16.7%
Price / earnings	15.4×-6.4×	23.3×+9.9×	18.9×+4.8×	26.7×+16.1×	21.9×+8.6×
Price / sales	1.5×0.0×	1.9×+0.4×	1.5×-0.6×	1.4×-0.5×	1.4×-0.7×
Price / book	3.7×-0.4×	4.9×+0.8×	4×-1.3×	4.2×-0.7×	4.1×-1.5×
EV / EBITDA	3.5×+1.0×	5.1×+2.6×	3.5×0.0×	3×+0.4×	2.6×-0.5×
EV / sales	1.1×-0.2×	1.6×+0.2×	1.3×-0.8×	1.2×-0.3×	1.3×-0.5×
Free cash flow yield	28.6%+7.1pp	22.4%-0.6pp	26.2%+10.0pp	21.8%-4.4pp	21.5%-3.4pp
Earnings yield	6.5%+1.9pp	4.3%-3.2pp	5.3%-1.8pp	3.7%-5.7pp	4.6%-2.9pp
PEG ratio	0.2×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Collegium Pharmaceutical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?: Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?: Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.